TheraSourceLLC Logo
Discovering novel therapeutics for inflammatory diseases
  • Home
  • About Us
  • Technologies
    • rhMFG-E8
      • Acute Kidney Injury
      • Hemorrhagic Shock
      • Inflammatory Bowel Disease
    • Ghrelin
      • Acute Ischemic Stroke
      • Acute Radiation Syndrome
    • Ghrelin plus Growth Hormone
      • Sepsis
  • Partnership
  • In the News
  • Contact Us
  • Menu

Technologies

Posted on September 30, 2014May 3, 2016 by Howard

TheraSource has developed novel recombinant proteins and peptides to treat inflammatory diseases including acute kidney injury (AKI), inflammatory bowel disease (IBD), acute ischemic stroke, acute radiation syndrome, sepsis and shock.

 
 

rhMFG-E8

Acute Kidney Injury

Hemorrhagic Shock

Inflammatory Bowel Disease

Ghrelin

Acute Ischemic Stroke

Acute Radiation Syndrome

Ghrelin plus Growth Hormone

Sepsis

Return To Top
  • Company Overview
  • Technologies
  • Partnership
  • In the News
  • Contact Us

350 Community Drive · Manhasset · NY 11030 · United States 516.562.1370 Info@therasourcellc.com
Copyright © 2016 TheraSource, LLC